Australia markets open in 5 hours 31 minutes

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,057.00-8.35 (-0.78%)
At close: 03:30PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 1.07T
Enterprise value 1.07T
Trailing P/E 25.81
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.38
Price/book (mrq)5.41
Enterprise value/revenue 5.33
Enterprise value/EBITDA 17.09

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 379.37%
S&P500 52-week change 333.16%
52-week high 31,324.30
52-week low 3567.75
50-day moving average 31,134.81
200-day moving average 31,016.93

Share statistics

Avg vol (3-month) 32.44M
Avg vol (10-day) 31.66M
Shares outstanding 51.01B
Implied shares outstanding 61.01B
Float 8249.06M
% held by insiders 175.15%
% held by institutions 113.46%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 40.28%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 40.83
Payout ratio 414.54%
Dividend date 3N/A
Ex-dividend date 426 July 2024
Last split factor 25:1
Last split date 306 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 20.34%
Operating margin (ttm)30.51%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)206.15B
Revenue per share (ttm)204.01
Quarterly revenue growth (yoy)20.80%
Gross profit (ttm)N/A
EBITDA 58.08B
Net income avi to common (ttm)41.69B
Diluted EPS (ttm)41.23
Quarterly earnings growth (yoy)30.60%

Balance sheet

Total cash (mrq)13.58B
Total cash per share (mrq)13.49
Total debt (mrq)8.22B
Total debt/equity (mrq)3.72%
Current ratio (mrq)N/A
Book value per share (mrq)197.07

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A